|
1.
|
Wade D, Bomam A, Wåhlin B, Drain CM,
Andreu D, Boman HG and Merrifield RB: All-D amino acid-containing
channel-forming antibiotic peptides. Proc Natl Acad Sci USA.
87:4761–4765. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Reddy KV, Yedery RD and Aranha C:
Antimicrobial peptides: premises and promises. Int J Antimicrob
Agents. 24:536–547. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Andrès E and Dimarcq JL: Clinical
development of antimicrobial peptides. Int J Antimicrob Agents.
25:448–452. 2005.
|
|
4.
|
Jenssen H, Hamill P and Hancock RE:
Peptide antimicrobial agents. Clin Microbial Rev. 19:491–511. 2006.
View Article : Google Scholar
|
|
5.
|
Boman HG and Hultmark D: Cell-free
immunity in insects. Annu Rev Microbiol. 41:103–126. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Zasloff M: Magainins, a class of
antimicrobial peptides from Xenopus skin: isolation,
characterization of two active forms, and partial cDNA sequence of
a precursor. Proc Natl Acad Sci USA. 84:5449–5453. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lee JY, Boman A, Sun CX, Andersson M,
Jörnvall H, Mutt V and Boman HG: Antimicrobial peptides from pig
intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci
USA. 86:9159–9162. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Clark DP, Durell S, Maloy WL and Zasloff
M: Ranalexin: a novel antimicrobial peptide from bullfrog (Rana
catasbeiana) skin, structurally related to the bacterial
antibiotic polymyxin. J Biol Chem. 269:10849–10855. 1994.PubMed/NCBI
|
|
9.
|
Iketani M, Nishimura H, Akayama K, Yamano
Y and Morishima I: Minimum structure of peptidoglycan required for
induction of antibacterial protein synthesis in the silkworm,
Bombyx mori. Insect Biochem Mol Biol. 29:19–24. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Piers KL and Hancock RE: The interaction
of a recombinant cecropin/mellitin hybrid peptide with the outer
membrane of Pseudomonas aeruginosa. Mol Microbiol.
12:951–958. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Falla TJ, Karunaratne DN and Hancock RE:
Mode of action of the antimicrobial peptide indolicidin. J Biol
Chem. 271:3031996. View Article : Google Scholar
|
|
12.
|
Vaara M and Porro M: Group of peptides
that act synergistically with hydrophobic antibiotics against
gram-negative enteric bacteria. Antimicrob Agents Chemother.
40:1801–1805. 1996.PubMed/NCBI
|
|
13.
|
Hancock RE: Antibacterial peptides and the
outer membranes of gram-negative bacilli. J Med Microbiol. 46:1–3.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Falla T and Hancock RE: Improved activity
of a synthetic indolicidin analog. Antimicrob Agents Chemother.
41:771–775. 1997.PubMed/NCBI
|
|
15.
|
Viljanen P, Matsunaga H, Kimura Y and
Vaara M: The outer membrane permeability-increasing action of
deacylpolymyxins. J Antibiot (Tokyo). 44:517–523. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
National Committee for Clinical Laboratory
Standards: Methods for Dilution Antimicrobial Susceptibility Tests
for Bacteria that Grow Aerobically. 3rd edition. Approved standard
M7-A3.National Committee for Clinical Laboratory Standards;
Villanova, PA: 1993
|
|
17.
|
Bone RC: Gram-positive organisms and
sepsis. Arch Intern Med. 154:26–34. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Andreu D, Merrifield RB, Steiner H and
Boman HG: N-terminal analogues of cecropin A: synthesis,
antibacterial activity and conformational properties. Biochemistry.
24:1683–1688. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Blondelle SE and Houghton RA: Hemolytic
and antimicrobial activities in the twenty-four individual omission
analogues of melittin. Biochemistry. 30:4671–4678. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Moore AJ, Beazley WD, Bibby MC and Devine
DA: Antimicrobial activity of cecropins. J Antimicrob Chemother.
37:1077–1089. 1996. View Article : Google Scholar
|
|
21.
|
DeLucca AJ, Blond JM, Jacks TJ, Grimm C,
Cleveland TE and Walsh TJ: Fungicidal activity of cecropin A.
Antimicrob Agents Chemother. 41:481–483. 1997.PubMed/NCBI
|
|
22.
|
Giacometti A, Cirioni O, Barchiesi F, Del
Prete MS and Scalise G: Antimicrobial activity of polycationic
peptides. Peptides. 20:1265–1273. 1999. View Article : Google Scholar
|
|
23.
|
Raetz CR: Biochemistry of endotoxins. Annu
Rev Biochem. 59:129–170. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Schletter J, Heine H, Ulmer AJ and
Rietschel ET: Molecular mechanisms of endotoxin activity. Arch
Microbiol. 164:383–389. 1995. View Article : Google Scholar
|
|
25.
|
Howe RA and Spencer RC: Macrolides for the
treatment of Pseudomonas aeruginosa infections? J Antimicrob
Chemother. 40:153–155. 1997. View Article : Google Scholar
|
|
26.
|
Yi GS, Park CB, Kim SC and Cheong C:
Solution structure of an antimicrobial peptide buforin II. FEBS
Lett. 398:87–90. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Molinari G, Guzmán CA, Pesce A and Schito
GC: Inhibition of Pseudomonas aeruginosa virulence factors
by subinhibitory concentrations of azithromycin and other macrolide
antibiotics. J Antimicrob Chemother. 31:681–688. 1993.
|
|
28.
|
Yasuda H, Ajiki Y, Koga T, Kawada H and
Yokota T: Interaction between biofilms formed by Pseudomonas
aeruginosa and clarithromycin. Antimicrob Agents Chemother.
37:1749–1755. 1993. View Article : Google Scholar : PubMed/NCBI
|
